Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial

European consensus on the histopathology of inflammatory bowel disease

Fernando Magro, Cord Langner, Ann Driessen et al. · Journal of Crohn s and Colitis · 2013 · 718 citations · Full text

Medicine, Immunology, Pathology +17

Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

C. Chapuis Cellier, Tarek Sahmoud, Eric Froguel et al. · Gut · 1994 · 435 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis

Kevin Winthrop, Hisashi Yamanaka, Hernán Valdez et al. · Arthritis & Rheumatology · 2014 · 350 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects

Matthieu Allez, Konstantinos Κarmiris, Édouard Louis et al. · Journal of Crohn s and Colitis · 2010 · 337 citations · Full text

Medicine, Immunology, Pharmacology +15

IBD and health-related quality of life — Discovering the true impact

Sanna Lönnfors, Séverine Vermeire, Marco Greco et al. · Journal of Crohn s and Colitis · 2014 · 331 citations · Full text

Medicine, Internal Medicine, Gastroenterology +12